CORRELATION OF SOLUBLE ADHESION MOLECULES IN THE PERIPHERAL-BLOOD OF SCLERODERMA PATIENTS WITH THEIR IN-SITU EXPRESSION AND WITH DISEASE-ACTIVITY

被引：133

作者：

GRUSCHWITZ, MS

HORNSTEIN, OP

VONDENDRIESCH, P

机构：

[1] University of Erlangen-Nuremberg, Erlangen

来源：

ARTHRITIS AND RHEUMATISM | 1995年 / 38卷 / 02期

关键词：

D O I：

10.1002/art.1780380206

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objective. To correlate serum levels of the soluble adhesion molecules intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1(VCAM-1), E-selectin, and P-selectin with (a) clinical disease activity and progression and (b) the in situ expression and distribution of these adhesion molecules in lesional skin, in patients with systemic sclerosis (SSc). Methods. Serum samples from 12 SSc patients and 36 healthy controls were examined by enzyme-linked immunosorbent assay. Immunohistologic staining was carried out on cryostat sections of lesional skin. Results. Patients whose SSc was in the early inflammatory stage or who had prominent disease progression showed elevated serum levels of soluble adhesion molecules. Serum levels correlated positively with the expression of these molecules on endothelial cells and fibroblasts in lesional skin. Conclusion. Serum levels of soluble ICAM-1, VCAM-1, P-selectin, and, to a lesser degree, E-selectin correlate well with their in situ activity and with clinical disease activity. These parameters therefore provide a useful tool for the characterization of disease stage, progression, and prognosis in SSc.

引用

页码：184 / 189

页数：6

共 16 条

[1]

Krieg T, Meurer M, Systemic scleroderma, J Am Acad Dermatol, 18, pp. 457-481, (1988)

[2]

Gruschwitz M, von den Driesch P, Kellner I, Hornstein OP, Sterry W, Expression of adhesion proteins involved in cell‐cell and cell‐matrix interactions in the skin of patients with progressive systemic sclerosis, J Am Acad Dermatol, 27, pp. 169-177, (1992)

[3]

Carson CW, Beall LD, Hunder GG, Johnson CM, Newman W, Serum ELAM‐1 is increased in vasculitis, scleroderma, and systemic lupus erythematosus, J Rheumatol, 20, pp. 809-814, (1993)

[4]

Seth R, Raymond FD, Makgoba MW, Circulating ICAM‐1 isoforms: Diagnostic prospects for inflammatory and immune disorders, Lancet, 338, pp. 83-84, (1991)

[5]

Bevilacqua MP, Endothelial‐leukocyte adhesion molecules, Annu Rev Immunol, 11, pp. 767-804, (1993)

[6]

Arbeitsgruppe Sklerodermie” der Arbeitsgemeinschaft Dermatologische Forschung (ADF): Klinik der progressiven systemischen Sklerodermie (PSS), Hautarzt, 37, pp. 320-324, (1986)

[7]

Preliminary criteria for the classification of systemic sclerosis (scleroderma), Arthritis Rheum, 23, pp. 581-590, (1980)

[8]

Kahaleh MB, Sultany GL, Smith EA, Huffstutter JE, Loadholt CB, Le Roy EC, A modified scleroderma skin scoring method, Clin Exp Rheumatol, 4, pp. 969-972, (1986)

[9]

Shimizu Y, Newman W, Gopal TV, Horgan KF, Graber N, Beall LD, van Seventer GA, Shaw S, Four molecular pathways of T‐cell adhesion to endothelial cells: roles of LFA‐1, VCAM‐1, and ELAM‐1 and changes in pathway hierarchy under different activation conditions, J Cell Biol, 113, pp. 1203-1212, (1991)

[10]

Rohde D, Schluter-Wigger W, Mielke V, von den Driesch P, von Gaudecker B, Sterry W, Infiltration of both T cells and neutrophils in the skin is accompanied by the expression of endothelial leukocyte adhesion molecule‐1 (ELAM‐1): an immunohistochemical and ultrastructural study, J Invest Dermatol, 98, pp. 794-799, (1992)

← 1 2 →